GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q1 2015. The put-call ratio across all filers is 1.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $217,000 | +7.4% | 4,983 | -5.7% | 0.01% | 0.0% |
| Q3 2021 | $202,000 | -67.9% | 5,284 | -68.4% | 0.01% | -78.6% |
| Q3 2020 | $629,000 | +209.9% | 16,721 | +236.4% | 0.03% | +154.5% |
| Q2 2020 | $203,000 | -22.5% | 4,971 | -23.0% | 0.01% | -52.2% |
| Q3 2017 | $262,000 | -6.1% | 6,459 | -0.1% | 0.02% | -8.0% |
| Q2 2017 | $279,000 | +4.1% | 6,467 | +1.6% | 0.02% | 0.0% |
| Q1 2017 | $268,000 | +20.7% | 6,367 | +23.9% | 0.02% | +8.7% |
| Q3 2016 | $222,000 | -17.5% | 5,137 | -17.3% | 0.02% | -11.5% |
| Q2 2016 | $269,000 | -1.1% | 6,210 | -7.5% | 0.03% | -13.3% |
| Q1 2016 | $272,000 | +15.3% | 6,714 | +14.8% | 0.03% | +20.0% |
| Q4 2015 | $236,000 | -99.8% | 5,850 | +88.8% | 0.02% | +127.3% |
| Q4 2014 | $132,405,000 | – | 3,098 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |